Health ❯ Pharmaceuticals

Drug Efficacy

Clinical Trials COVID-19 Treatments Clinical Research Placebo Effect Weight Management Clinical Studies Investor Impact GLP-1 Drugs Adverse Effects Drug Development Process Weight Loss Treatments Side Effects Phenylephrine Cardiovascular Risk Drug Side Effects Monoclonal Antibodies Nanobody Technology Patient Safety Weight Loss Preclinical Studies Chemical Compounds

Lead-Plaintiff Deadline Nears in MoonLake Securities Suits After SLK Trial Miss

Complaints allege the company overstated sonelokimab’s superiority, leading to an 89.9% stock collapse after Phase 3 results.

MoonLake Faces Expanding Securities Suits as Lead-Plaintiff Deadline Nears

aTyr Investors Face Dec. 8 Deadline as Rival Lawsuits Over Failed Sarcoidosis Trial Intensify

MoonLake Investors Courted by Law Firms as Lead‑Plaintiff Deadline Nears in SDNY Securities Case

Texas Sues Bristol-Myers Squibb and Sanofi Over Alleged Deception on Plavix’s Effectiveness

aTyr Investor Lawsuit Drive Heats Up as Dec. 8 Lead-Plaintiff Deadline Nears

New aTyr Class Action Expands Investor Window After EFZO-FIT Failure

aTyr Faces Securities Suit After Phase 3 Failure Triggers 83% Stock Crash

Roivant’s Brepocitinib Succeeds in 52-Week Dermatomyositis Phase 3 as Companies Target 2026 FDA Filing